Commissural alignment and the ACURATE neo2 transcatheter aortic valve: Impact on valve performance.
aortic regurgitation
commissural alignment
patient‐prosthesis mismatch
transcatheter aortic valve replacement
valve performance
Journal
Catheterization and cardiovascular interventions : official journal of the Society for Cardiac Angiography & Interventions
ISSN: 1522-726X
Titre abrégé: Catheter Cardiovasc Interv
Pays: United States
ID NLM: 100884139
Informations de publication
Date de publication:
19 May 2024
19 May 2024
Historique:
revised:
26
02
2024
received:
15
11
2023
accepted:
08
05
2024
medline:
20
5
2024
pubmed:
20
5
2024
entrez:
20
5
2024
Statut:
aheadofprint
Résumé
Transcatheter aortic valve replacement (TAVR) is increasingly being used to treat severe aortic stenosis in younger patients. Accordingly, lifetime management regarding future reintervention and coronary access is a concern. To assess the impact of commissural alignment on ACURATE neo2 transcatheter aortic valve (TAV) performance. COMALIGN-neo2 was an observational, retrospective study enrolling consecutive TAVR patients treated with the ACURATE neo2 (October 2021 to October 2022). The degree of commissural (mis)-alignment (CMA) with the native aortic valve commissures was determined and transvalvular gradient, effective orifice area, patient-prosthesis mismatch (PPM), and aortic regurgitation (AR) were assessed. Among 825 patients, the mean age was 80.7 years and 42% were female. Commissural alignment was achieved in 60% of cases; mild (26%), moderate (9%), and severe misalignment (5%) were found less often. Severe PPM occurred more frequently in patients with severe CMA (14.7%) compared to aligned valves (p = 0.034). By multivariate analysis, severe CMA (odds ratio [OR]: 3.12, 95% confidence interval [CI] [1.09-8.90]; p = 0.033) and lack of postdilatation (OR: 3.85, [1.33-11.1]; p = 0.012) were associated with severe PPM. Higher rates of ≥mild AR (51.4%) were found in TAVs implanted with severe CMA compared to aligned (34.3%), mildly (38.1%) or moderately (36.0%) misaligned TAVs (p = 0.030). Multivariate analysis identified severe CMA (OR: 2.05, [1.05-4.02]; p = 0.037) to be an independent predictor of ≥mild AR. COMALIGN-neo2 is the largest study to date assessing the impact of commissural alignment on acute TAV performance. Severe CMA with the ACURATE neo2 platform was associated with worse valve hemodynamics and increased risk for mild AR.
Sections du résumé
BACKGROUND
BACKGROUND
Transcatheter aortic valve replacement (TAVR) is increasingly being used to treat severe aortic stenosis in younger patients. Accordingly, lifetime management regarding future reintervention and coronary access is a concern.
AIMS
OBJECTIVE
To assess the impact of commissural alignment on ACURATE neo2 transcatheter aortic valve (TAV) performance.
METHODS
METHODS
COMALIGN-neo2 was an observational, retrospective study enrolling consecutive TAVR patients treated with the ACURATE neo2 (October 2021 to October 2022). The degree of commissural (mis)-alignment (CMA) with the native aortic valve commissures was determined and transvalvular gradient, effective orifice area, patient-prosthesis mismatch (PPM), and aortic regurgitation (AR) were assessed.
RESULTS
RESULTS
Among 825 patients, the mean age was 80.7 years and 42% were female. Commissural alignment was achieved in 60% of cases; mild (26%), moderate (9%), and severe misalignment (5%) were found less often. Severe PPM occurred more frequently in patients with severe CMA (14.7%) compared to aligned valves (p = 0.034). By multivariate analysis, severe CMA (odds ratio [OR]: 3.12, 95% confidence interval [CI] [1.09-8.90]; p = 0.033) and lack of postdilatation (OR: 3.85, [1.33-11.1]; p = 0.012) were associated with severe PPM. Higher rates of ≥mild AR (51.4%) were found in TAVs implanted with severe CMA compared to aligned (34.3%), mildly (38.1%) or moderately (36.0%) misaligned TAVs (p = 0.030). Multivariate analysis identified severe CMA (OR: 2.05, [1.05-4.02]; p = 0.037) to be an independent predictor of ≥mild AR.
CONCLUSIONS
CONCLUSIONS
COMALIGN-neo2 is the largest study to date assessing the impact of commissural alignment on acute TAV performance. Severe CMA with the ACURATE neo2 platform was associated with worse valve hemodynamics and increased risk for mild AR.
Types de publication
Journal Article
Langues
eng
Sous-ensembles de citation
IM
Informations de copyright
© 2024 Wiley Periodicals LLC.
Références
Auffret V, Ridard C, Salerno N, Sorrentino S. Unmet needs in TAVR: conduction disturbances and management of coronary artery disease. J Clin Med. 2022;11(21):6256.
Tang GHL, Amat‐Santos IJ, De Backer O, et al. Rationale, definitions, techniques, and outcomes of commissural alignment in TAVR. JACC Cardiovasc Interv. 2022;15(15):1497‐1518.
Sá MP, Ramlawi B, Sicouri S, et al. Lifetime management of aortic valve disease: aligning surgical and transcatheter armamentarium to set the tone for the present and the future. J Card Surg. 2022;37(1):205‐213.
Tarantini G, Nai Fovino L, Scotti A, et al. Coronary access after transcatheter aortic valve replacement with commissural alignment: the ALIGN‐ACCESS study. Circ Cardiovasc Interv. 2022;15(2):e011045.
Bieliauskas G, Wong I, Bajoras V, et al. Patient‐specific implantation technique to obtain neo‐commissural alignment with self‐expanding transcatheter aortic valves. JACC Cardiovasc Interv. 2021;14(19):2097‐2108.
Pibarot P. Prosthesis‐patient mismatch: definition, clinical impact, and prevention. Heart. 2006;92(8):1022‐1029.
Zoghbi WA, Asch FM, Bruce C, et al. Guidelines for the evaluation of valvular regurgitation After percutaneous valve repair or replacement. J Am Soc Echocardiogr. 2019;32(4):431‐475.
Lanz J, Kim WK, Walther T, et al. Safety and efficacy of a self‐expanding versus a balloon‐expandable bioprosthesis for transcatheter aortic valve replacement in patients with symptomatic severe aortic stenosis: a randomised non‐inferiority trial. Lancet. 2019;394(10209):1619‐1628.
Meduri CU, Rück A, Linder R, et al. Commissural alignment with ACURATE neo2 valve in an unselected population. JACC Cardiovasc Interv. 2023;16(6):670‐677.
De Marco F, Casenghi M, Spagnolo P, et al. A patient‐specific algorithm to achieve commissural alignment with acurate neo: the sextant technique. Catheter Cardiovasc Interv. 2021;98(6):E847‐E854.
Tang GHL, Sengupta A, Alexis SL, et al. Conventional versus modified delivery system technique in commissural alignment from the Evolut low‐risk CT substudy. Catheter Cardiovasc Interv. 2022;99(3):924‐931.
Tang GHL, Zaid S, Gupta E, et al. Impact of initial Evolut transcatheter aortic valve replacement deployment orientation on final valve orientation and coronary reaccess: a pilot study. Circ Cardiovasc Interv. 2019;12:e008044.
Buono A, Morello A, Pero G, et al. Commissural alignment with new‐generation self‐expanding transcatheter heart valves during aortic replacement. cardiovascular revascularization. Medicine. 2022;40:139‐143.
Khera S, Krishnamoorthy P, Sharma SK, et al. Improved commissural alignment in TAVR with the newest Evolut FX self‐expanding supra‐annular valve: first‐in‐human experience. JACC Cardiovasc Interv. 2023;16:498‐500.
Egron S, Fujita B, Gullón L, et al. Radial force: an underestimated parameter in oversizing transcatheter aortic valve replacement prostheses: in vitro analysis with five commercialized valves. ASAIO J. 2018;64(4):536‐543.
Kim W‐K, Tamburino C, Möllmann H, et al. Clinical outcomes of the ACURATE neo2 transcatheter heart valve: a prospective, multicentre, observational, post‐market surveillance study. EuroIntervention. 2023;19(1):83‐92.
Kim WK, Möllmann H, Liebetrau C, et al. The ACURATE neo transcatheter heart valve. JACC Cardiovasc Interv. 2018;11(17):1721‐1729.
Toggweiler S, Brinkert M, Wolfrum M, et al. Paravalvular leak after implantation of the ACURATE neo and the ACURATE neo2 transcatheter heart valve. Cardiovasc Revasc Med. 2022;45:37‐43.
Bailey J, Curzen N, Bressloff NW. The impact of imperfect frame deployment and rotational orientation on stress within the prosthetic leaflets during transcatheter aortic valve implantation. J Biomech. 2017;53:22‐28.
Khan JM, Rogers T, Weissman G, et al. Anatomical characteristics associated with hypoattenuated leaflet thickening in low‐risk patients undergoing transcatheter aortic valve replacement. Cardiovasc Revasc Med. 2021;27:1‐6.
Raschpichler M, Flint N, Yoon SH, et al. Commissural alignment after balloon‐expandable transcatheter aortic valve replacement is associated with improved hemodynamic outcomes. JACC Cardiovasc Interv. 2022;15(11):1126‐1136.